Ablation Devices Global Market - Forecast to 2023

 Published On: Mar, 2017 |    No of Pages: 365 |  Published By: IQ4I Research and Consultancy | Format: PDF
Request Free Sample
Ablation is the minimally invasive therapeutic tissue excision procedure used for a wide range of purposes, from cancerous or diseased tissue removal, to the removal of abnormally conducting cardiac tissue in atrial fibrillation and others. The growing adoption of minimally invasive procedures is pushing the researchers to innovate and improvise existing ablation technologies for better patient care.

The ablation device global market is expected to grow at high single digit CAGR to reach $20,995.5 million by 2023. The ablation device global market by technology is segmented into thermal ablation and non thermal ablation. The thermal ablation technologies are radiation therapy, cryoablation, radiofrequency, laser, ultrasound, microwave, and hydrothermal ablation technology. Among thermal ablation, radiofrequency ablation accounted for the largest share in 2016 and microwave is expected to grow at highest CAGR from 2016-2023. Non thermal technology includes electroporation, mechanical ablation and others (Chemical). Among non thermal ablation technologies, electroporation generated the largest share in 2016, and is expected to grow at a mid single digit CAGR from 2016-2023.  

By application, the ablation device global market is segmented oncology, cardiovascular diseases, ophthalmology, cosmetology, gynaecology, general surgery, urology, orthopaedics, pain management and others. Atrial Fibrilation, Ventricular Tachycardia and Others are the segments in cardiovascular application. Oncology is holding the largest revenue in 2016 and cardiovascular application is expected to grow at a high CAGR from 2016-2023.

By end-users, the market is segmented into hospitals, ambulatory surgical centres and speciality clinics. Hospitals generated the largest revenue in 2016 and are expected to grow at high CAGR from 2016-2023

By geography, the market is segmented into North America, Europe, Asia-Pacific and Rest of World. North America holds the largest market share in 2016, followed by Europe and Asia. The APAC regions tend to be an emerging market with an opportunity for growth with a highest CAGR from 2016-2023 and are likely to be a destination of investment for new investors in the ablation device market.

The ablation device market is expected to grow at high single digit CAGR from 2016-2023. The major factor influencing the growth are increasing number of ablation procedures, rising incidence of cancer, emergence of next-generation ablation products and technologies, growing adoption of minimally invasive procedures, and improving reimbursement scenario in established markets are some of the factors driving the market.  However, reuse and reprocessing of devices in developing countries, healthcare cost-containment measures, stringent regulatory guidelines, and challenges in therapeutic procedures are some of the factors hampering the market.

The ablation device global market is a competitive and all the active players in this market are involved in innovating new and advanced products to maintain their market shares. The key players in the ablation device global market include Boston Scientific Corporation (U.S.), Johnson and Johnson (U.S.), Abbott laboratories (St Jude Medical) (U.S.), Medtronic (Ireland), Stryker Corporation (U.S.), Elekta AB (Sweden), Olympus Corporation (Japan), ConMed Corporation (U.S.), Hologic (U.S.), Articure Inc. (U.S.), Angiodynamics Inc. (U.S.), Smith and Nephew plc (U.K.), and Varian Medical Systems (U.S.).

The report provides an in depth market analysis of the above mentioned segments across the following regions:
ē North America
ē Europe
ē Asia-Pacific
ē Rest of the World (RoW)
1 EXECUTIVE SUMMARY 22
2 INTRODUCTION 29
2.1 KEY TAKE AWAYS 29
2.2 REPORT DESCRIPTION 30
2.3 MARKETS COVERED 31
2.4 STAKEHOLDERS 34
2.5 RESEARCH METHODOLOGY 34
2.5.1 MARKET SIZE ESTIMATION 35
2.5.2 MARKET BREAKDOWN & DATA TRIANGULATION 38
2.5.3 SECONDARY SOURCES 39
2.5.4 KEY DATA POINTS FROM SECONDARY SOURCES 40
2.5.5 PRIMARY SOURCES 40
2.5.6 KEY DATA POINTS FROM PRIMARY SOURCES 41
2.5.7 ASSUMPTIONS 41
3 MARKET ANALYSIS 43
3.1 INTRODUCTION 43
3.2 MARKET SEGMENTATION 44
3.3 FACTORS INFLUENCING MARKET 46
3.3.1 DRIVERS AND OPPORTUNITIES 47
3.3.1.1 Increasing Aging Population 47
3.3.1.2 Rising Incidence of Cancer and Cardiovascular Diseases 47
3.3.1.3 Growing Adoption of Minimally Invasive Procedures 48
3.3.1.4 Improving Reimbursement Scenario In Established Markets 49
3.3.1.5 Emergence of Next-Generation Ablation Products and Technologies 51
3.3.1.6 Increasing Number of Ablation Procedures 52
3.3.1.7 Increasing Funding for the Development of Novel Ablation Device 53
3.3.1.8 Emerging APAC Markets 54
3.3.2 RESTRAINTS & THREATS 55
3.3.2.1 Reuse And Reprocessing of Devices in Developing Countries 55
3.3.2.2 Healthcare Cost Containment Measures 56
3.3.2.3 Stringent Regulatory Approvals 56
3.3.2.4 Challenges in Therapeutic Procedures 57
3.4 UPCOMING TECHNOLOGY 58
3.5 REIMBURSEMENT 68
3.6 REGULATORY AFFAIRS 74
3.6.1 U.S. 75
3.6.2 EUROPE 75
3.6.3 INDIA 76
3.6.4 CHINA 77
3.6.5 JAPAN 78
3.7 PATENT TRENDS 78
3.8 SUPPLY CHAIN ANALYSIS 80
3.9 PORTERíS FIVE FORCE ANALYSIS 83
3.9.1 THREAT OF NEW ENTRANTS 84
3.9.2 THREAT OF SUBSTITUTES 85
3.9.3 BARGAINING POWER OF SUPPLIERS 86
3.9.4 BARGAINING POWER OF BUYERS 86
3.9.5 RIVALRY AMONG EXISTING COMPETITORS 86
3.10 MARKET SHARE ANALYSIS 88
3.10.1 MARKET SHARE ANALYSIS BY ABLATION DEVICE MAJOR PLAYERS 88
3.10.2 MARKET SHARE ANALYSIS BY ATRIAL FIBRILLATION ABLATION DEVICE MAJOR PLAYERS 92
3.10.3 MARKET SHARE ANALYSIS BY RADIATION ABLATION DEVICE MAJOR PLAYERS 94
4 ABLATION DEVICES GLOBAL MARKET, BY TECHNOLOGY 96
4.1 INTRODUCTION 96
4.2 THERMAL ABLATION 99
4.2.1 RADIOFREQUENCY ABLATION 104
4.2.2 LASER ABLATION TECHNOLOGY 110
4.2.3 MICROWAVE ABLATION TECHNOLOGY 114
4.2.4 ULTRASOUND ABLATION TECHNOLOGY 118
4.2.5 RADIATION ABLATION TECHNOLOGY 125
4.2.6 CRYOABLATION TECHNOLOGY 130
4.2.7 HYDROTHERMAL ABLATION TECHNOLOGY 133
4.3 NON-THERMAL TECHNOLOGY BASED ABLATION 136
4.3.1 ELECTROPORATION ABLATION TECHNOLOGY 141
4.3.2 MECHANICAL ABLATION TECHNOLOGY 142
4.3.3 OTHERS 146
5 ABLATION DEVICES GLOBAL MARKET, BY APPLICATION 148
5.1 INTRODUCTION 148
5.2 ONCOLOGY 150
5.3 CARDIOVASCULAR 154
5.3.1 ATRIAL FIBRILATION (AF/AFIB) 157
5.3.2 VENTRICULAR TACHYCARDIA (VT) 159
5.3.3 OTHERS 161
5.4 OPHTHALMOLOGY 164
5.5 COSMETOLOGY 166
5.6 GYNECOLOGY 168
5.7 GENERAL SURGERY 171
5.8 UROLOGY 173
5.9 ORTHOPEDICS 176
5.10 PAIN MANAGEMENT 178
5.11 OTHER 180
6 ABLATION DEVICES GLOBAL MARKET, BY END-USERS 182
6.1 INTRODUCTION 182
6.2 HOSPITALS 184
6.3 AMBULATORY SURGICAL CENTRES 186
6.4 SPECIALITY CLINICS 188
7 REGIONAL MARKET ANALYSIS 190
7.1 INTRODUCTION 190
7.2 NORTH AMERICA 192
7.2.1 U.S. 200
7.2.2 OTHERS 203
7.3 EUROPE 205
7.3.1 U.K. 213
7.3.2 GERMANY 216
7.3.3 FRANCE 217
7.3.4 OTHERS 219
7.4 ASIA PACIFIC 221
7.4.1 INDIA 229
7.4.2 CHINA 231
7.4.3 JAPAN 234
7.4.4 OTHERS 236
7.5 REST OF THE WORLD 238
7.5.1 MIDDLE EAST 246
7.5.2 BRAZIL 248
7.5.3 OTHERS 250
8 COMPANY DEVELOPMENTS 253
8.1 INTRODUCTION 253
8.1.1 MERGER AND ACQUISITION AS A MAJOR GROWTH STRATEGY OF ABLATION DEVICE MARKET PLAYERS 254
8.2 MERGERS AND ACQUISITIONS 254
8.3 APPROVAL 258
8.4 NEW PRODUCT LAUNCH 262
8.5 AGREEMENTS PARTNERSHIPS, COLLABORATIONS   &   JOINT VENTURES 265
8.6 BUSINESS EXPANSION 266
9 MAJOR PLAYER PROFILES 268
9.1 ABBOTT LABORATORIES (ST JUDE MEDICAL) 268
9.1.1 OVERVIEW 268
9.1.2 FINANCIALS 269
9.1.3 PRODUCT PORTFOLIO 271
9.1.4 KEY DEVELOPMENTS 273
9.1.5 BUSINESS STRATEGY 274
9.1.6 SWOT ANALYSIS 275
9.2 ANGIODYNAMICS INC. 276
9.2.1 OVERVIEW 276
9.2.2 FINANCIALS 277
9.2.3 PRODUCT PORTFOLIO 279
9.2.4 KEY DEVELOPMENTS 280
9.2.5 BUSINESS STRATEGY 280
9.2.6 SWOT ANALYSIS 281
9.3 ARTICURE INC. 282
9.3.1 OVERVIEW 282
9.3.2 FINANCIALS 283
9.3.3 PRODUCT PORTFOLIO 285
9.3.4 KEY DEVELOPMENTS 286
9.3.5 BUSINESS STRATEGY 287
9.3.6 SWOT ANALYSIS 288
9.4 BOSTON SCIENTIFIC CORPORATION 289
9.4.1 OVERVIEW 289
9.4.2 FINANCIALS 290
9.4.3 PRODUCT PORTFOLIO 292
9.4.4 KEY DEVELOPMENTS 293
9.4.5 BUSINESS STRATEGY 294
9.4.6 SWOT ANALYSIS 295
9.5 CONMED CORPORATION 296
9.5.1 OVERVIEW 296
9.5.2 FINANCIALS 297
9.5.3 PRODUCT PORTFOLIO 299
9.5.4 KEY DEVELOPMENTS 300
9.5.5 BUSINESS STRATEGY 301
9.5.6 SWOT ANALYSIS 302
9.6 ELEKTA AB 303
9.6.1 OVERVIEW 303
9.6.2 FINANCIALS 304
9.6.3 PRODUCT PORTFOLIO 306
9.6.4 KEY DEVELOPMENTS 307
9.6.5 BUSINESS STRATEGY 308
9.6.6 SWOT ANALYSIS 309
9.7 HOLOGIC INC. 310
9.7.1 OVERVIEW 310
9.7.2 FINANCIALS 311
9.7.3 PRODUCT PORTFOLIO 313
9.7.4 KEY DEVELOPMENTS 313
9.7.5 BUSINESS STRATEGY 314
9.7.6 SWOT ANALYSIS 315
9.8 JOHNSON & JOHNSON 316
9.8.1 OVERVIEW 316
9.8.2 FINANCIALS 317
9.8.3 PRODUCT PORTFOLIO 320
9.8.4 KEY DEVELOPMENTS 321
9.8.5 BUSINESS STRATEGY 322
9.8.6 SWOT ANALYSIS 323
9.9 MEDTRONIC, PLC 324
9.9.1 OVERVIEW 324
9.9.2 FINANCIALS 325
9.9.3 PRODUCT PORTFOLIO 331
9.9.4 KEY DEVELOPMENTS 334
9.9.5 BUSINESS STRATEGY 335
9.9.6 SWOT ANALYSIS 336
9.10 OLYMPUS CORPORATION 337
9.10.1 OVERVIEW 337
9.10.2 FINANCIALS 338
9.10.3 PRODUCT PORTFOLIO 340
9.10.4 KEY DEVELOPMENTS 341
9.10.5 BUSINESS STRATEGY 341
9.10.6 SWOT ANALYSIS 342
9.11 SMITH & NEPHEW PLC 343
9.11.1 OVERVIEW 343
9.11.2 FINANCIALS 344
9.11.3 PRODUCT PORTFOLIO 346
9.11.4 KEY DEVELOPMENTS 347
9.11.5 BUSINESS STRATEGY 348
9.11.6 SWOT ANALYSIS 349
9.12 STRYKER CORPORATION 350
9.12.1 OVERVIEW 350
9.12.2 FINANCIALS 351
9.12.3 PRODUCT PORTFOLIO 355
9.12.4 KEY DEVELOPMENTS 356
9.12.5 BUSINESS STRATEGY 356
9.12.6 SWOT ANALYSIS 357
9.13 VARIAN MEDICAL SYSTEMS 358
9.13.1 OVERVIEW 358
9.13.2 FINANCIALS 359
9.13.3 PRODUCT PORTFOLIO 361
9.13.4 KEY DEVELOPMENTS 362
9.13.5 BUSINESS STRATEGY 363
9.13.6 SWOT ANALYSIS 364

LIST OF TABLES

TABLE 1 ABLATION DEVICES GLOBAL MARKET REVENUE,  BY REGION, (2015-2023) ($MN) 25
TABLE 2 ABLATION DEVICES GLOBAL MARKET REVENUE,  BY TECHNOLOGY, (2015-2023) ($MN) 26
TABLE 3 ABLATION DEVICES GLOBAL MARKET, BY APPLICATION  (2015-2023) ($MN) 27
TABLE 4 ABLATION DEVICES GLOBAL MARKET REVENUE,  BY END-USER, (2015-2023) ($MN) 28
TABLE 5 ABLATION DEVICE TECHNIQUES GLOBAL MARKET REVENUE,  BY REGION, (2015-2023) ($MN) 98
TABLE 6 ABLATION DEVICE GLOBAL MARKET REVENUE,  BY TECHNOLOGY, (2015-2023) ($MN) 99
TABLE 7 THERMAL TECHNOLOGY IN ABLATION DEVICE GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN) 102
TABLE 8 THERMAL TECHNOLOGY IN ABLATION DEVICE GLOBAL MARKET REVENUE, BY TYPES, (2015-2023) ($MN) 103
TABLE 9 RADIOFREQUENCY TECHNOLOGY IN ABLATION DEVICE  GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN) 106
TABLE 10 LASER TECHNOLOGY IN ABLATION DEVICE GLOBAL  MARKET REVENUE, BY REGION, (2015-2023) ($MN) 111
TABLE 11 MICROWAVE TECHNOLOGY IN ABLATION DEVICE  GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN) 117
TABLE 12 ULTRASOUND TECHNOLOGY IN ABLATION DEVICE GLOBAL  MARKET REVENUE, BY REGION, (2015-2023) ($MN) 120
TABLE 13 RADIATION TECHNOLOGY IN ABLATION DEVICE GLOBAL  MARKET REVENUE, BY REGION, (2015-2023) ($MN) 127
TABLE 14 CRYOABLATION TECHNOLOGY IN ABLATION DEVICE GLOBAL  MARKET REVENUE, BY REGION, (2015-2023) ($MN) 132
TABLE 15 HYDROTHERMAL TECHNOLOGY IN ABLATION DEVICE GLOBAL  MARKET REVENUE, BY REGION, (2015-2023) ($MN) 136
TABLE 16 NON-THERMAL TECHNOLOGY IN ABLATION DEVICE  GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN) 138
TABLE 17 NON-THERMAL TECHNOLOGY IN ABLATION DEVICE  GLOBAL MARKET REVENUE, BY TYPE, (2015-2023) ($MN) 139
TABLE 18 ELECTROPORATION TECHNOLOGY IN ABLATION DEVICE  GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN) 142
TABLE 19 MECHANICAL TECHNOLOGY IN ABLATION DEVICE GLOBAL  MARKET REVENUE, BY REGION, (2015-2023) ($MN) 145
TABLE 20 OTHER NON-THERMAL TECHNOLOGIES IN ABLATION DEVICE  GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN) 147
TABLE 21 ABLATION DEVICES GLOBAL MARKET, BY APPLICATION  (2015-2023) ($MN) 150
TABLE 22 ONCOLOGY APPLICATION OF ABLATION DEVICE GLOBAL  MARKET REVENUE, BY REGION, (2015-2023) ($MN) 154
TABLE 23 CARDIOVASCULAR APPLICATION OF ABLATION DEVICE  GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN) 156
TABLE 24 CARDIOVASCULAR APPLICATION OF ABLATION DEVICE  GLOBAL MARKET, BY TYPES(2015-2023) ($MN) 157
TABLE 25 ATRIAL FIBRILATION ABLATION DEVICE GLOBAL MARKET  REVENUE, BY REGION, (2015-2023) ($MN) 158
TABLE 26 ATRIAL FIBRILATION PROCEDURAL VOLUME GLOBAL  MARKET, BY REGION, (2015-2023) (NO'S) 159
TABLE 27 VENTRICULAR TACHYCARDIA ABLATION DEVICE  GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN) 160
TABLE 28 VENTRICULAR TACHYCARDIA PROCEDURAL VOLUME  GLOBAL MARKET, BY REGION, (2015-2023) (NO'S) 161
TABLE 29 OTHER CARDIOVASCULAR ABLATION DEVICE GLOBAL  MARKET REVENUE, BY REGION, (2015-2023) ($MN) 163
TABLE 30 OTHER CARDIOVASULAR PROCEDURAL VOLUME GLOBAL  MARKET, BY REGION, (2015-2023) (NO'S) 164
TABLE 31 OPHTHALMOLOGY APPLICATION OF ABLATION DEVICE GLOBAL  MARKET REVENUE, BY REGION, (2015-2023) ($MN) 166
TABLE 32 COSMETOLOGY APPLICATION OF ABLATION DEVICE GLOBAL  MARKET REVENUE, BY REGION, (2015-2023) ($MN) 168
TABLE 33 GYNECOLOGY APPLICATION OF ABLATION DEVICE GLOBAL  MARKET, BY REGION (2015-2023) ($MN) 171
TABLE 34 GENERAL SURGERY APPLICATION OF ABLATION DEVICE  GLOBAL MARKET, BY REGION (2015-2023) ($MN) 173
TABLE 35 UROLOGY APPLICATION OF ABLATION DEVICE  GLOBAL MARKET, BY REGION(2015-2023) ($MN) 176
TABLE 36 ORTHOPEDIC APPLICATION OF ABLATION DEVICE  GLOBAL MARKET, BY REGION(2015-2023) ($MN) 178
TABLE 37 PAIN MANAGEMENT APPLICATION OF ABLATION DEVICE  GLOBAL MARKET, BY REGION(2015-2023) ($MN) 180
TABLE 38 OTHER DISEASES APPLICATION OF ABLATION DEVICE  GLOBAL MARKET, BY REGION (2015-2023) ($MN) 181
TABLE 39 ABLATION DEVICE GLOBAL MARKET REVENUE,  BY END-USER, (2015-2023) ($MN) 184
TABLE 40 HOSPITALS IN ABLATION DEVICE  ENDUSERS GLOBAL  MARKET REVENUE, BY REGION, (2015-2023) ($MN) 186
TABLE 41 AMBULATORY SURGICAL CENTRE IN ABLATION DEVICE  GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN) 187
TABLE 42 SPECIALITY CLINICS IN ABLATION DEVICE  END USERS  GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN) 189
TABLE 43 ABLATION DEVICE GLOBAL MARKET REVENUE,  BY REGION, (2015-2023) ($MN) 192
TABLE 44 NORTH AMERICA ABLATION DEVICE MARKET REVENUE,  BY TECHNOLOGY, (2015-2023) ($MN) 196
TABLE 45 NORTH AMERICAN THERMAL TECHNOLOGY ABLATION DEVICE  MARKET REVENUE, BY TYPE (2015-2023) ($MN) 197
TABLE 46 NORTH AMERICAN NON THERMAL TECHNOLOGY ABLATION  DEVICE MARKET REVENUE, BY TYPE (2015-2023) ($MN) 198
TABLE 47 NORTH AMERICAN ABLATION DEVICE MARKET REVENUE,  BY APPLICATION, (2015-2023) ($MN) 199
TABLE 48 NORTH AMERICAN ABLATION DEVICE MARKET REVENUE,  BY END USERS, (2015-2023) ($MN) 200
TABLE 49 EUROPE ABLATION DEVICE MARKET REVENUE,  BY TECHNOLOGY, (2015-2023) ($MN) 209
TABLE 50 EUROPE THERMAL TECHNOLOGY ABLATION DEVICE  MARKET REVENUE, BY TYPE (2015-2023) ($MN) 210
TABLE 51 EUROPE NON THERMAL TECHNOLOGY ABLATION DEVICE  MARKET REVENUE, BY TYPE (2015-2023) ($MN) 211
TABLE 52 EUROPE ABLATION DEVICE MARKET REVENUE,  BY APPLICATION, (2015-2023) ($MN) 212
TABLE 53 EUROPE ABLATION DEVICE MARKET REVENUE,  BY END USERS, (2015-2023) ($MN) 213
TABLE 54 ASIA PACIFIC ABLATION DEVICE MARKET REVENUE,  BY TECHNOLOGY, (2015-2023) ($MN) 225
TABLE 55 ASIA PACIFIC THERMAL TECHNOLOGY ABLATION DEVICE  MARKET REVENUE, BY TYPE (2015-2023) ($MN) 226
TABLE 56 ASIA PACIFIC NON THERMAL TECHNOLOGY ABLATION  DEVICE MARKET REVENUE, BY TYPE (2015-2023) ($MN) 227
TABLE 57 ASIA PACIFIC ABLATION DEVICE MARKET REVENUE,  BY APPLICATION, (2015-2023) ($MN) 228
TABLE 58 ASIA PACIFIC ABLATION DEVICE MARKET REVENUE,  BY END USERS, (2015-2023) ($MN) 229
TABLE 59 ROW ABLATION DEVICE MARKET REVENUE,  BY TECHNOLOGY, (2015-2023) ($MN) 242
TABLE 60 ROW THERMAL TECHNOLOGY ABLATION DEVICE MARKET  REVENUE, BY TYPE (2015-2023) ($MN) 243
TABLE 61 ROW NON-THERMAL TECHNOLOGY ABLATION DEVICE  MARKET REVENUE, BY TYPE (2015-2023) ($MN) 244
TABLE 62 ROW ABLATION DEVICE MARKET REVENUE,  BY APPLICATION, (2015-2023) ($MN) 245
TABLE 63 ROW ABLATION DEVICE MARKET REVENUE,  BY END USERS, (2015-2023) ($MN) 246
TABLE 64 MERGERS AND ACQUITIONS (2015-2016) 255
TABLE 65 APPROVALS (2015-2016) 259
TABLE 66 NEW PRODUCT LAUNCH (2015-2016) 263
TABLE 67 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS &  JOINT VENTURES (2015-2016) 265
TABLE 68 BUSINESS EXPANSION (2015-2016) 267
TABLE 69 ABBOTT LABORATORIES: TOTAL REVENUE AND  R&D EXPENSES, (2014-2016) ($MN) 269
TABLE 70 ABBOTT LABORATORIES: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN) 270
TABLE 71 ABBOTT LABORATORIES: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN) 271
TABLE 72 ANGIODYNAMICS INC: TOTAL REVENUE AND  R&D EXPENSES, (2014-2016) ($MN) 277
TABLE 73 ANGIODYNAMICS INC: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN) 278
TABLE 74 ANGIODYNAMICS INC: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN) 279
TABLE 75 ARTICURE INC: TOTAL REVENUE AND  R&D EXPENSES, (2014-2016) ($MN) 283
TABLE 76 ARTICURE INC: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN) 284
TABLE 77 ARTICURE INC: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN) 285
TABLE 78 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE AND  R&D EXPENSES, (2014-2016) ($MN) 290
TABLE 79 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN) 291
TABLE 80 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN) 292
TABLE 81 CONMED CORPORATION: TOTAL REVENUE AND  R&D EXPENSES, (2014-2016) ($MN) 297
TABLE 82 CONMED CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN) 298
TABLE 83 CONMED CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN) 299
TABLE 84 ELEKTA AB : TOTAL REVENUE AND  R&D EXPENSES, (2014-2016) ($MN) 304
TABLE 85 ELEKTA AB : TOTAL REVENUE,  BY SEGMENTS (2014-2016) ($MN) 305
TABLE 86 ELEKTA AB : TOTAL REVENUE,  BY GEOGRAPHY (2014-2016) ($MN) 306
TABLE 87 HOLOGIC INC.: TOTAL REVENUE AND  R&D EXPENSES, (2014-2016) ($MN) 311
TABLE 88 HOLOGIC INC: TOTAL REVENUE, BY SEGMENTS,  (2014-2016) ($MN) 312
TABLE 89 HOLOGIC INC: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN) 313
TABLE 90 JOHNSON & JOHNSON: TOTAL REVENUE AND  R&D EXPENSES, (2014-2016) ($MN) 317
TABLE 91 JOHNSON & JOHNSON: TOTAL REVENUE,  BY SEGMENTS, (2014-2016) ($MN) 318
TABLE 92 JOHNSON & JOHNSON: TOTAL REVENUE,  BY GEOGRAPHY, (2014-2016) ($MN) 319
TABLE 93 MEDTRONIC, PLC: TOTAL REVENUE AND  R&D EXPENSES, (2014-2016) ($MN) 325
TABLE 94 MEDTRONIC, PLC: TOTAL REVENUE,  BY SEGMENTS, (2014-2016) ($MN) 326
TABLE 95 MEDTRONIC, PLC: CARDIAC AND VASCULAR GROUP REVENUE,  BY SUB-SEGMENTS, (2014-2016) ($MN) 327
TABLE 96 MEDTRONIC, PLC: MINIMALLY INVASIVE THERAPIES REVENUE,  BY SUB-SEGMENTS, (2014-2016) ($MN) 328
TABLE 97 MEDTRONIC, PLC: RESTORATIVE THERAPIES GROUP REVENUE, BY SUB-SEGMENTS, (2014-2016) ($MN) 329
TABLE 98 MEDTRONIC, PLC: TOTAL REVENUE,  BY GEOGRAPHY, (2014-2016) ($MN) 330
TABLE 99 OLYMPUS CORPORATION: TOTAL REVENUE AND  R&D EXPENSES  (2014-2016) ($MN) 338
TABLE 100 OLYMPUS CORPORATION : TOTAL REVENUE,  BY SEGMENTS (2014-2016) ($MN) 339
TABLE 101 OLYMPUS CORPORATION: TOTAL REVENUE,  BY GEOGRAPHY (2014-2016) ($MN) 340
TABLE 102 SMITH & NEPHEW PLC: TOTAL REVENUE AND  R&D EXPENSES, (2014-2016) ($MN) 344
TABLE 103 SMITH & NEPHEW PLC: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN) 345
TABLE 104 SMITH & NEPHEW PLC: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN) 346
TABLE 105 STRYKER CORPORATION: TOTAL REVENUE AND  R&D EXPENSES, (2014-2016) ($MN) 351
TABLE 106 STRYKER CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN) 352
TABLE 107 STRYKER CORPORATION: TOTAL NEUROTECHNOLOGY AND  SPINE REVENUE, BY SEGMENTS, (2014-2016) ($MN) 353
TABLE 108 STRYKER CORPORATION: TOTAL MEDSURG REVENUE,  BY SEGMENTS, (2014-2016) ($MN) 354
TABLE 109 STRYKER CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN) 355
TABLE 110 VARIAN MEDICAL SYSTEMS: TOTAL REVENUE AND  R&D EXPENSES, (2014-2016) ($MN) 359
TABLE 111 VARIAN MEDICAL SYSTEMS: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN) 360
TABLE 112 VARIAN MEDICAL SYSTEMS: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN) 361

LIST OF FIGURES

FIGURE 1 ABLATION DEVICE GLOBAL MARKET SHARE,  BY GEOGRAPHY (2015-2023) 24
FIGURE 2 RESEARCH METHODOLOGY: ABLATION DEVICE GLOBAL MARKET 35
FIGURE 3 ABLATION DEVICE GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH 36
FIGURE 4 ABLATION DEVICE GLOBAL MARKET: FORECASTING MODEL 37
FIGURE 5 ABLATION DEVICE GLOBAL MARKET: MARKET BREAKDOWN & DATA TRIANGULATION 38
FIGURE 6 ABLATION DEVICES GLOBAL MARKET: MARKET SEGMENTATION 45
FIGURE 7 MARKET DYNAMICS 46
FIGURE 8 ABLATION DEVICES MARKET:PATENT FILING BY MAJOR PLAYERS  (2011-2016) 79
FIGURE 9 ABLATION DEVICE GLOBAL MARKET: SUPPLY CHAIN ANALYSIS 82
FIGURE 10 ABLATION DEVICES GLOBAL MARKET: PORTERíS ANALYSIS 84
FIGURE 11 ABLATION DEVICE GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, (2016) 88
FIGURE 12 ATRIAL FIBRILLATION ABLATION DEVICE GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2016 92
FIGURE 13 RADIATION TECHNOLOGY ABLATION DEVICE GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, (2016) 94
FIGURE 14 ABLATION DEVICE GLOBAL MARKET REVENUE, BY TECHNOLOGY (2015-2023) ($MN) 97
FIGURE 15 THERMAL TECHNOLOGY IN ABLATION DEVICE TECHNOLOGY GLOBAL MARKET REVENUE, BY TYPES (2016) ($MN) 101
FIGURE 16 RADIOFREQUENCY ABLATION DEVICE GLOBAL MARKET SHARE, BY APPLICATION (2016) (%) 107
FIGURE 17 LASER ABLATION DEVICE GLOBAL MARKET SHARE,  BY APPLICATION (2016) (%) 112
FIGURE 18 THERMAL TECHNOLOGY IN ABLATION DEVICE GLOBAL MARKET REVENUE, MICROWAVE APPLICATION MARKET SHARE (2016) (%) 118
FIGURE 19 ULTRASOUND ABLATION DEVICE GLOBAL  MARKET SHARE, BY APPLICATION (2016) (%) 121
FIGURE 20 RADIATION ABLATION DEVICE GLOBAL MARKET  SHARE, BY APPLICATION (2016) (%) 128
FIGURE 21 THERMAL TECHNOLOGY IN ABLATION DEVICE GLOBAL MARKET REVENUE, CRYOABLATION APPLICATION MARKET SHARE (2016) (%)  133
FIGURE 22 NON-THERMAL TECHNOLOGY IN ABLATION DEVICE GLOBAL MARKET REVENUE, BY TYPE (2016 VíS 2023) ($MN) 140
FIGURE 23 ABLATION DEVICE GLOBAL MARKET SHARE,  BY APPLICATIONS, (2016) (%) 149
FIGURE 24 CANCER ABLATION PROCEDURE VOLUME,  BY DISEASE TYPES, (2016) (%) 153
FIGURE 25 ABLATION DEVICE GLOBAL MARKET REVENUE,  BY END USERS (2015-2023) ($MN) 183
FIGURE 26 ABLATION DEVICE GLOBAL MARKET REVENUE, BY REGION  (2015-2023) CAGR (%) 191
FIGURE 27 OUTLOOK OF NORTH AMERICA ABLATION DEVICE MARKET,  BY TECHNOLOGY (2016 VíS 2023) ($MN) 194
FIGURE 28 OUTLOOK OF NORTH AMERICA ABLATION DEVICE MARKET,  BY APPLICATIONS & END USERS (2016 VíS 2023) ($MN) 195
FIGURE 29 OUTLOOK OF U.S. ABLATION DEVICE MARKET, BY TECHNOLOGY, APPLICATION & END USERS (2016 VíS 2023) ($MN) 203
FIGURE 30 OUTLOOK OF OTHER NORTH AMERICAN ABLATION DEVICE MARKET, BY APPLICATIONS, TECHNIQUES & END-USERS (2016 VíS 2023) ($MN) 205
FIGURE 31 OUTLOOK OF EUROPE ABLATION DEVICE MARKET, BY TECHNOLOGY (2016 VíS 2023) ($MN) 207
FIGURE 32 OUTLOOK OF EUROPE ABLATION DEVICE MARKET,  BY APPLICATION & END USERS (2016 VíS 2023) ($MN) 208
FIGURE 33 OUTLOOK OF U.K. ABLATION DEVICE MARKET, BY TECHNOLOGY, APPLICATION & END USERS (2016 VíS 2023) ($MN) 215
FIGURE 34 OUTLOOK OF GERMANY ABLATION DEVICE MARKET, BY TECHNOLOGY, APPLICATION & END USERS (2016 VíS 2023) ($MN) 217
FIGURE 35 OUTLOOK OF FRANCE ABLATION DEVICE MARKET, BY TECHNOLOGY, APPLICATION & END USERS (2016 VíS 2023) ($MN) 219
FIGURE 36 OUTLOOK OF OTHER EUROPEAN ABLATION DEVICE MARKET,  BY TECHNOLOGY, APPLICATIONS, & END-USERS (2016 VíS 2023) ($MN) 221
FIGURE 37 OUTLOOK OF ASIA-PACIFIC ABLATION DEVICE MARKET,  BY TECHNOLOGY (2016 VíS 2023) ($MN) 223
FIGURE 38 OUTLOOK OF ASIA-PACIFIC ABLATION DEVICE MARKET,  BY APPLICATION AND END USERS (2016 VíS 2023) ($MN) 224
FIGURE 39 OUTLOOK OF INDIA ABLATION DEVICE MARKET, BY TECHNOLOGY, APPLICATION & END USERS (2016 VíS 2023) ($MN) 231
FIGURE 40 OUTLOOK OF CHINA ABLATION DEVICE MARKET, BY TECHNOLOGY, APPLICATION & END USERS (2016 VíS 2023) ($MN) 233
FIGURE 41 OUTLOOK OF JAPAN ABLATION DEVICE MARKET, BY TECHNOLOGY, APPLICATION & END USERS (2016 VíS 2023) ($MN) 236
FIGURE 42 OUTLOOK OF OTHER ASIA PACIFIC ABLATION DEVICE MARKET,  BY TECHNOLOGY, APPLICATIONS & END-USERS (2016 VíS 2023) ($MN) 238
FIGURE 43 OUTLOOK OF ROW ABLATION DEVICE MARKET REVENUE,  BY TECHNOLOGY (2016 VíS 2023) ($MN) 240
FIGURE 44 OUTLOOK OF ROW ABLATION DEVICE MARKET, BY APPLICATION & END-USERS (2016 VíS 2023) ($MN) 241
FIGURE 45 OUTLOOK OF MIDDLE EAST ABLATION DEVICE MARKET, BY TECHNOLOGY, APPLICATION & ENDUSERS (2016 VíS 2023) ($MN) 248
FIGURE 46 OUTLOOK OF BRAZIL ABLATION DEVICE MARKET, BY TECHNOLOGY, APPLICATION & END USERS (2016 VíS 2023) ($MN) 250
FIGURE 47 OUTLOOK OF OTHER ROW REGION ABLATION DEVICE MARKET,BY TECHNOLOGY, APPLICATION & ENDUSER (2016 VíS 2023) ($MN) 252
FIGURE 48 KEY GROWTH STRATEGIES (2015-2016) 253
FIGURE 49 SWOT: ABBOTT LABORATORIES 275
FIGURE 50 SWOT: ANGIODYNAMICS 281
FIGURE 51 SWOT: ARTICURE INC 288
FIGURE 52 SWOT: BOSTON SCIENTIFIC CORPORATION 295
FIGURE 53 SWOT: CONMED CORPORATION 302
FIGURE 54 SWOT: ELEKTA AB 309
FIGURE 55 SWOT: HOLOGIC INC 315
FIGURE 56 SWOT: JOHNSON AND JOHNSON 323
FIGURE 57 SWOT: MEDTRONIC PLC 336
FIGURE 58 SWOT: OLYMPUS CORPORATION 342
FIGURE 59 SWOT: SMITH AND NEPHEW PLC 349
FIGURE 60 SWOT: STRYKER CORPORATION 357
FIGURE 61 SWOT: VARIAN MEDICAL SYSTEMS 364

If the above report does not have the information suitable for your business, we can provide custom research that can be lucrative for your business or enhance your profession.